Mesna
Formulations: - Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule Oral > Solid: 400 mg; 600 mg Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule; 100 mg per mL in 2 mL ampoule Oral > Solid > tablet: 400 mg; 600 mg Oral > Other: 600 mg Oral > Solid > tablet: 400 mg Indications: - Unspecified malignant neoplasms of ill-defined or unspecified sites - Osteosarcoma of bone and articular cartilage of other specified sites - Burkitt lymphoma including Burkitt leukaemia - Ewing sarcoma of bone and articular cartilage of unspecified sites - Malignant neoplasms of kidney, except renal pelvis - Other specified malignant neoplasms of the ovary - Germ cell tumour of testis - Rhabdomyosarcoma primary site Source: EML workbook import